LNTH240517P70000
- 0.25
- 0.000.00%
Lantheus Newsroom
Lantheus Stock (NASDAQ:LNTH): High Growth Powered by Radiopharma Innovations
Lantheus(LNTH.US) Officer Sells US$26,219.49 in Common Stock
$Lantheus(LNTH.US)$ Officer Sabens Andrea sold 341 shares of common stock on May 13, 2024 at an average price of $76.89 for a total value of $26,219.49.Source: Announcement What is statement of change
Lantheus Holdings Names Jeffrey Humphrey to Be Medical Chief
By Ben Glickman Lantheus Holdings named Jeffrey Humphrey as its next chief medical officer, effective May 28. The Bedford, Mass.-based company, which makes medical imaging products, said Wednesday t
Lantheus Announces Executive Team Reshuffle With New CSO
Press Release: Lantheus Announces Executive Appointments to Accelerate Innovation
Lantheus Announces Executive Appointments to Accelerate Innovation Jeffrey S. Humphrey, MD appointed Chief Medical Officer; Jean-Claude Provost, MD named Chief Science Officer BEDFORD, Mass., May 1
Under The Bonnet, Lantheus Holdings' (NASDAQ:LNTH) Returns Look Impressive
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Ideally, a business will show two trends; firstly a growing retur
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript
Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up
Evaluating Lantheus Holdings: Insights From 5 Financial Analysts
Lantheus Holdings (NASDAQ:LNTH) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The following table encapsulates their recent ratings,
Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating
Lantheus Holdings (LNTH) has an average rating of buy and price targets ranging from $83 to $128, according to analysts polled by Capital IQ. Price: 78.18, Change: +10.79, Percent Change: +16.01
Strong Buy Rating for Lantheus Holdings Amidst Robust Financials and Growth Prospects
Lantheus Holdings Is Maintained at Buy by Mizuho
Lantheus Holdings Is Maintained at Buy by Mizuho
Express News | Mizuho Maintains Buy on Lantheus Holdings, Raises Price Target to $100
Lantheus Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 27.73% Mizuho $90 → $100 Maintains Buy 04/18/2024 26.45% B. Riley Securities $95 → $99 Maintain
Express News | Lantheus Holdings Inc : Truist Securities Raises Target Price to $96 From $82
Express News | Lantheus Holdings Inc : Jefferies Raises Target Price to $100 From $90
Analysts' Top Healthcare Picks: Lantheus (LNTH), Bicycle Therapeutics (BCYC)
Earnings Call Summary | Lantheus(LNTH.US) Q1 2024 Earnings Conference
The following is a summary of the Lantheus Holdings, Inc. (LNTH) Q1 2024 Earnings Call Transcript:Financial Performance:Lantheus reported consolidated Q1 2024 net revenue of $370 million, a 23% increa
Top Gap Ups and Downs on Thursday: LIN, ING, JD and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal